Alterity Therapeutics Limited (ATHE) Earnings History
Annual and quarterly earnings data from 2002 to 2025
Loading earnings history...
ATHE EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
ATHE Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 97.7% | -268.0% | -223.4% |
| 2024 | 94.7% | -487.7% | -475.8% |
| 2023 | 92.7% | -373.7% | -352.5% |
| 2022 | 92.9% | -302.6% | -250.7% |
| 2021 | 91.7% | -349.8% | -352.8% |
Download Data
Export ATHE earnings history in CSV or JSON format
Free sign-in required to download data
Alterity Therapeutics Limited (ATHE) Earnings Overview
As of May 8, 2026, Alterity Therapeutics Limited (ATHE) reported trailing twelve-month net income of -$31M, reflecting +63.5% year-over-year growth. The company earned $-2.51 per diluted share over the past four quarters, with a net profit margin of -223.4%.
Looking at the long-term picture, ATHE's historical earnings data spans multiple years. The company achieved its highest annual net income of -$5M in fiscal 2003.
Alterity Therapeutics Limited is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including PRTA (-$151M net income, -2520.6% margin), ACAD ($376M net income, 36.5% margin), SAVA (-$106M net income), ATHE has outperformed on profitability metrics. Compare ATHE vs PRTA →
ATHE Earnings vs Peers
Earnings metrics vs comparable public companies
ATHE Historical Earnings Data (2002–2025)
24 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$12M | +36.5% | -$15M | $-1.14 | -223.4% | -268.0% |
| 2024 | -$19M | -38.5% | -$20M | $-3.12 | -475.8% | -487.7% |
| 2023 | -$14M | -7.5% | -$15M | $-3.42 | -352.5% | -373.7% |
| 2022 | -$13M | +16.1% | -$16M | $-3.18 | -250.7% | -302.6% |
| 2021 | -$15M | -52.2% | -$15M | $-5.40 | -352.8% | -349.8% |
| 2020 | -$10M | +15.9% | -$10M | $-6.48 | - | - |
| 2019 | -$12M | -44.7% | -$13M | $-11.64 | -11020.8% | -11713.7% |
| 2018 | -$8M | -9.6% | -$8M | $-9.30 | -4108.8% | -3862.5% |
| 2017 | -$8M | +2.4% | -$7M | $-8.46 | -5696.6% | -5197.9% |
| 2016 | -$8M | -31.3% | -$9M | $-8.70 | -5418.3% | -6019.2% |
See ATHE's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ATHE Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ATHE vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonATHE — Frequently Asked Questions
Quick answers to the most common questions about buying ATHE stock.
Is ATHE growing earnings?
ATHE EPS is $-2.51, with earnings growth accelerating to +63.5%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-31M.
What are ATHE's profit margins?
Alterity Therapeutics Limited net margin is -223.4%, with operating margin at -268.0%. Below-average margins reflect competitive or cost pressures.
How consistent are ATHE's earnings?
ATHE earnings data spans 2002-2025. The accelerating earnings trend is +63.5% YoY. Historical data enables comparison across business cycles.